Filing metadata

Accession number
0000905148-24-000531
Form type
Form 3
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
Feb 09, 2024
Reporting period
Feb 08, 2024
Description
Initial ownership

Explore SEC Filings Hub